Best Dividend Aristocrats 2026: Halftime Scorecard
A July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesA July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...
A big EBITDA leap can capture attention, but insider trades often tell a different story. This guide explains why thi...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Rivian readies its lower-cost R2 for April deliveries, a pivotal move as analysts weigh its power to expand beyond pr...
The AI era is shifting how businesses operate and how investors pick winners. As agents arrived. stocks track emerges...
Kroger's margin-led growth and private-label strength are driving a re-rating away from Walmart's ad-driven model, si...
Analysts weigh whether Credo can reach $350 by 2028 as AI infrastructure spending stays strong and the company accele...
As Wiley (WLY) gears up for its 2026 earnings, investors should focus on segment growth, margin trajectory, and the c...
Meta Platforms is weighing a bold move into prediction markets, boosting investor interest and triggering a rally. An...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
As remittance and digital payments evolve, Western Union faces a mixed but improving picture. This article breaks dow...
Kaspi.kz faces a pivotal year as it expands its super app, grows its loan book, and navigates regional headwinds. Thi...